To obtain clues about the potential clinical implications of miR-935/HIF1A axis dysregulation in triple-negative 3D cultures, we performed an overall survival analysis using Kaplan–Meier analysis in a cohort of breast cancer patients, as described previously [44]. The gene discussed is HIF1A; the disease is breast carcinoma.